Hypogonadism and its treatment among prostate cancer survivors.

Edward J Choi, Perry Xu, Farouk M El-Khatib, Linda M Huynh, Faysal A Yafi

International journal of impotence research 2021 May

filter terms:

Adult-onset hypogonadism (AOH) is associated with sexual dysfunction, poor bone mineralization, decreased muscle mass, metabolic syndrome disorder, and cognitive suppression. Historically, testosterone has been contraindicated in men with a history of prostate cancer. However, there has been a modern resurgence in re-evaluating this belief. Not only can testosterone be safely utilized to alleviate AOH symptoms in prostate cancer survivors, it has been also touted as a treatment option for aggressive prostatic cancer. While much work remains in understanding the relationship between testosterone and prostate cancer, those who survive this disease should not be automatically turned away from an opportunity to be treated and restored.

Citation

Edward J Choi, Perry Xu, Farouk M El-Khatib, Linda M Huynh, Faysal A Yafi. Hypogonadism and its treatment among prostate cancer survivors. International journal of impotence research. 2021 May;33(4):480-487